• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC Back to Search Results
Model Number 20226
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/14/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that stent dislodgement occurred, requiring an additional device.The target lesion was located in the mildly tortuous and non-calcified iliac and renal arteries.Following pre-dilatation with a 6.0 x 80, 135cm mustang balloon catheter and placing a new 7f non-boston scientific sheath, a 8.0x40x75cm express ld stent was selected for use.However, when the express ld went over the bifurcation and was just about to be placed over the lesion, the stent dislodged.The physician decided to leave the stent and deployed it using a new mustang balloon catheter.Another express ld stent was used to cover the remainder of the lesion.There were no complications reported and the patient was scheduled for follow-up.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the express ld was returned for analysis.The balloon was received loosely folded.The balloon appears to have been subjected to positive pressure.No stent received on balloon material.A visual and tactile examination identified no kinks or damage to the shaft of the device.A visual examination of the device identified no issues with the markerbands or tip.
 
Event or Problem Description
It was reported that stent dislodgement occurred, requiring an additional device.The target lesion was located in the mildly tortuous and non-calcified iliac and renal arteries.Following pre-dilatation with a 6.0 x 80, 135cm mustang balloon catheter and placing a new 7f non-boston scientific sheath, a 8.0x40x75cm express ld stent was selected for use.However, when the express ld went over the bifurcation and was just about to be placed over the lesion, the stent dislodged.The physician decided to leave the stent and deployed it using a new mustang balloon catheter.Another express ld stent was used to cover the remainder of the lesion.There were no complications reported and the patient was scheduled for follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS LD ILIAC / BILIARY
Common Device Name
STENT, ILIAC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18845561
Report Number2124215-2024-10797
Device Sequence Number15536971
Product Code NIO
UDI-Device Identifier08714729392279
UDI-Public08714729392279
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K133110
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/26/2024
Device Model Number20226
Device Catalogue Number20226
Device Lot Number0027213299
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/14/2024
Supplement Date Received by Manufacturer04/29/2024
Initial Report FDA Received Date03/06/2024
Supplement Report FDA Received Date05/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/27/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
7F DESTINATION SHEATH; 7F DESTINATION SHEATH
Outcome Attributed to Adverse Event Required Intervention;
Patient Age77 YR
Patient SexFemale
Patient RaceBlack Or African American
-
-